1. US Food and Drug Administration. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. 2009. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf. [Accessed June 1, 2014].
2. US Food and Drug Administration. Clinical Outcome Assessment Qualification Program. October 11, 2013 update. Available from: http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DrugDevelopmentToolsQualificationProgram/ucm284077.htm. [Accessed June 1, 2014].
3. Walton MK, Powers JH, Hobart J, et al. Clinical outcomes assessments (COAs): a conceptual foundation. ISPOR ClinRO Task Force report. Value Health. In press.
4. US Food and Drug Administration. Measurement in clinical trials: review and qualification of clinical outcome assessments. In: Public Workshop; Silver Spring, MD; October 19, 2011. Available from: http://www.fda.gov/Drugs/NewsEvents/ucm276110.htm. [Accessed June 1, 2014].
5. Diary keeping in asthma: comparison of written and electronic methods;Hyland;BMJ,1993